Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TACROLIMUS SYSTEMIC Cause Transplant rejection? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Transplant rejection have been filed in association with TACROLIMUS SYSTEMIC. This represents 17.0% of all adverse event reports for TACROLIMUS SYSTEMIC.

8
Reports of Transplant rejection with TACROLIMUS SYSTEMIC
17.0%
of all TACROLIMUS SYSTEMIC reports
1
Deaths
0
Hospitalizations

How Dangerous Is Transplant rejection From TACROLIMUS SYSTEMIC?

Of the 8 reports, 1 (12.5%) resulted in death.

Is Transplant rejection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TACROLIMUS SYSTEMIC. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TACROLIMUS SYSTEMIC Cause?

Off label use (12) Neutropenia (5)

What Other Drugs Cause Transplant rejection?

TACROLIMUS (3,526) MYCOPHENOLATE MOFETIL (2,500) PREDNISONE (1,111) CYCLOSPORINE (903) PREDNISOLONE (860) METHYLPREDNISOLONE (779) SIROLIMUS (698) BASILIXIMAB (554) MYCOPHENOLIC ACID (445) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)

Related Pages

TACROLIMUS SYSTEMIC Full Profile All Transplant rejection Reports All Drugs Causing Transplant rejection TACROLIMUS SYSTEMIC Demographics